Briefing Chat: How Dolly Parton left her mark on science

In this episode:

00:18 Researchers celebrate Dolly Parton's contributions to scienceNature: Dolly Parton dies aged 80 — researchers celebrate her contributions to science

08:40 Phase III trial of melanoma vaccine shows promiseNature: Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?

Subscribe to Nature Briefing, an unmissable daily round-up of science news, opinion and analysis free in your inbox every weekday.

Hosted on Acast. See acast.com/privacy for more information.